Taiwan · Delayed Price · Currency is TWD HanchorBio Statistics
Total Valuation
HanchorBio has a market cap or net worth of TWD 19.53 billion. The enterprise value is 18.06 billion.
| Market Cap | 19.53B |
| Enterprise Value | 18.06B |
Important Dates
The next estimated earnings date is Friday, November 27, 2026.
| Earnings Date | Nov 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HanchorBio has 130.21 million shares outstanding. The number of shares has increased by 32.00% in one year.
| Current Share Class | 130.21M |
| Shares Outstanding | 130.21M |
| Shares Change (YoY) | +32.00% |
| Shares Change (QoQ) | +2.69% |
| Owned by Insiders (%) | 39.67% |
| Owned by Institutions (%) | 7.97% |
| Float | 78.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 60.70 |
| PB Ratio | 13.29 |
| P/TBV Ratio | 14.77 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 56.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.09, with a Debt / Equity ratio of 0.10.
| Current Ratio | 4.09 |
| Quick Ratio | 3.97 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.26 |
| Interest Coverage | -223.99 |
Financial Efficiency
Return on equity (ROE) is -85.55% and return on invested capital (ROIC) is -44.90%.
| Return on Equity (ROE) | -85.55% |
| Return on Assets (ROA) | -36.18% |
| Return on Invested Capital (ROIC) | -44.90% |
| Return on Capital Employed (ROCE) | -48.17% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 2.57M |
| Profits Per Employee | -4.58M |
| Employee Count | 127 |
| Asset Turnover | 0.26 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HanchorBio has paid 32.07 million in taxes.
| Income Tax | 32.07M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +93.30% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +93.30% |
| 50-Day Moving Average | 155.29 |
| 200-Day Moving Average | 135.94 |
| Relative Strength Index (RSI) | 42.92 |
| Average Volume (20 Days) | 195,026 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HanchorBio had revenue of TWD 321.77 million and -572.58 million in losses. Loss per share was -4.45.
| Revenue | 321.77M |
| Gross Profit | 312.84M |
| Operating Income | -724.62M |
| Pretax Income | -722.43M |
| Net Income | -572.58M |
| EBITDA | -698.66M |
| EBIT | -724.62M |
| Loss Per Share | -4.45 |
Balance Sheet
The company has 1.76 billion in cash and 140.12 million in debt, with a net cash position of 1.62 billion or 12.43 per share.
| Cash & Cash Equivalents | 1.76B |
| Total Debt | 140.12M |
| Net Cash | 1.62B |
| Net Cash Per Share | 12.43 |
| Equity (Book Value) | 1.47B |
| Book Value Per Share | 9.93 |
| Working Capital | 1.38B |
Cash Flow
In the last 12 months, operating cash flow was -515.28 million and capital expenditures -23.17 million, giving a free cash flow of -538.44 million.
| Operating Cash Flow | -515.28M |
| Capital Expenditures | -23.17M |
| Depreciation & Amortization | 25.96M |
| Net Borrowing | -24.53M |
| Free Cash Flow | -538.44M |
| FCF Per Share | -4.14 |
Margins
Gross margin is 97.23%, with operating and profit margins of -225.20% and -177.95%.
| Gross Margin | 97.23% |
| Operating Margin | -225.20% |
| Pretax Margin | -224.52% |
| Profit Margin | -177.95% |
| EBITDA Margin | -217.13% |
| EBIT Margin | -225.20% |
| FCF Margin | n/a |
Dividends & Yields
HanchorBio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.00% |
| Shareholder Yield | -32.00% |
| Earnings Yield | -2.93% |
| FCF Yield | -2.76% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HanchorBio has an Altman Z-Score of 14.04 and a Piotroski F-Score of 2.
| Altman Z-Score | 14.04 |
| Piotroski F-Score | 2 |